Stockscreener 앱 받기
1.05
0.00%
0.00
시간 외 거래:
1.05
전일 마감가:
$1.05
열려 있는:
$1.04
하루 거래량:
117.26K
Relative Volume:
0.18
시가총액:
$42.73M
수익:
-
순이익/손실:
$-63.97M
주가수익비율:
-0.5833
EPS:
-1.8
순현금흐름:
$-62.91M
1주 성능:
+0.96%
1개월 성능:
+5.00%
6개월 성능:
+10.78%
1년 성능:
+29.63%
1일 변동 폭
$1.03
$1.06
1주일 범위
$0.9901
$1.12
52주 변동 폭
$0.63
$1.76
아킬레스 테라퓨틱스 Stock (ACHL) Company Profile
ACHL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| ACHL | 1.05 | 42.73M | 0 | -63.97M | -62.91M | -1.80 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
아킬레스 테라퓨틱스 Stock (ACHL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-26 | 개시 | BofA Securities | Buy |
| 2021-04-26 | 개시 | Chardan Capital Markets | Buy |
| 2021-04-26 | 개시 | JP Morgan | Underweight |
| 2021-04-26 | 개시 | Oppenheimer | Outperform |
| 2021-04-26 | 개시 | Piper Sandler | Overweight |
아킬레스 테라퓨틱스 주식(ACHL)의 최신 뉴스
Achilles Therapeutics Reports Third Quarter 2024 Financial Results - GlobeNewswire Inc.
80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - 新浪香港
ACHL’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Check Out Achilles Therapeutics Plc ADR (ACHL)’s Trade Data Rather Than the Analysts’ Views - SETE News
Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
why Achilles Therapeutics Plc ADR [ACHL] is a Good Choice for Investors After New Price Target of $1.25 - The DBT News
What Analysts Were Expecting After PowerFleet Inc (NASDAQ: AIOT) rose 2.40% - Stocks Register
Achilles Thera shifts focus to new cancer treatment avenues - The Pharma Letter
Achilles Therapeutics ends TIL-based cancer therapy trials - Investing.com
You Should Read This Analysis Before Investing in Achilles Therapeutics Plc ADR (NASDAQ:ACHL) - US Post News
Achilles stock climbs on strategic focus (NASDAQ:ACHL) - Seeking Alpha
Achilles Therapeutics Announces Strategic Update - Yahoo Finance
Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - GlobeNewswire
Immunovant (IMVT) Up More Than 20% in Past 3 Months: Here's Why - Yahoo New Zealand News
Kodiak Sciences (KOD) Rises 60% in Past 3 Months: Here's Why - Yahoo Sport Australia
Achilles Therapeutics Plc ADR (ACHL) Clearly Signals Buy-Into the Stock: Don't ignore the signals – Sete News - SETE News
Amgen's (AMGN) Lumakras Meets Goal in New Lung Cancer Study - Yahoo Lifestyle UK
Blueprint Medicines' (BPMC) Ayvakit Meets Goal in PIONEER Study - Yahoo Movies UK
Waters (WAT) Walk-Up Solutions Boost Bioprocess Development - Yahoo Lifestyle UK
Achilles Therapeutics and Arcturus team up for cancer vaccine By Investing.com - Investing.com
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation ... - GlobeNewswire
Achilles Therapeutics Announces Research Collaboration with - GlobeNewswire
Achilles Therapeutics faces Nasdaq delisting over share price - Investing.com
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - GlobeNewswire
Horizon (HZNP) Inks Collaboration Deal with Q32 Bio for ADX-914 - Yahoo New Zealand News
Achilles Therapeutics Plc ADR's Shares Reel: -0.12% Quarterly Revenue Decline Amid 37.75M Market Cap – Invest ... - The InvestChronicle
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC ... - GlobeNewswire
Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference - GlobeNewswire
Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights - GlobeNewswire
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation - Quantisnow
What Makes Achilles Therapeutics PLC Sponsored ADR (ACHL) a New Buy Stock - Yahoo Finance
Apellis (APLS) Up More Than 60% in Past 3 Months: Here's Why - Nasdaq
Immuneering (IMRX) Files IND for Cancer Candidate IMM-1-104 - Yahoo Finance
Axsome (AXSM) Soars on FDA Nod for Depression Drug, Auvelity - Yahoo Finance Australia
Achilles Therapeutics Appoints James Taylor as Chief Business Officer and Cassian Yee, MD to Scientific Advisory Board - GlobeNewswire
Achilles Therapeutics PlcADR Shares Close the Day 10.1% HigherDaily Wrap - Nasdaq
Achilles Therapeutics Announces Pricing of Initial Public Offering - GlobeNewswire
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
아킬레스 테라퓨틱스 (ACHL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):